Danielle Marie Tartar, M.D., Ph.D.
Associate Program Director
Co-Director of Inpatient Dermatology
Co-Director of Autoimmune Dermatology Clinic
Associate Professor, Department of Dermatology
To see if Danielle Marie Tartar is accepting new patients, or for assistance finding a UC Davis doctor, please call 800-2-UCDAVIS (800-282-3284).
Locations and Contact
Phone: 916-734-6111
Clinic Phone: 916-286-6130
Philosophy of Care
My philosophy of care is to treat every patient with respect and dedication to meet their different needs. I believe in working together with each patient to develop the best plan of care for them.
Clinical Interests
Dr. Tartar is a board-certified dermatologist who treats all skin conditions, including skin cancers. She has a special interest in inflammatory and autoimmune skin diseases.
Research/Academic Interests
Dr. Tartar is the Associate Program Director for the Dermatology Residency Program and is very involved with resident education.
Division
Dermatology
Undergraduate School
B.S., Biology, University of Missouri, St. Louis MO 2004
Medical School
M.D., University of Missouri, Columbia MO 2013
Other School
Ph.D., Immunology, University of Missouri, Columbia MO 2009
Internship
Internal Medicine, University of Chicago, Chicago IL 2013-2014
Residency
Dermatology, UC Davis, Sacramento CA 2014-2017
Sacramento "Top Docs" for Dermatology, 2019, 2020, 2021
Outstanding faculty teaching award, chosen by UCD Dermatology Residents, 2019
Kligman Travel Award, Society of Investigative Dermatology Meeting, Scottsdale AZ, 2016
Hai J, Shawa H, Kim-Lim P, Wang JZ, Vy M, Fung MA, Sood A, Tartar DM. Systemic drug-related intertriginous and flexural exanthema induced by the Pfizer-BioNTech COVID-19 vaccine: A report of 2 cases. JAAD Case Rep. 2021 Dec;18:57-60. doi:10.1016/j.jdcr.2021.10.016. Epub 2021 Oct 26. PMID:34722840.
Carrington AE, Tartar DM, Sivamani RK. Anti-MDA-5 negative, anti-Ku positive clinically amyopathic dermatomyositis. Dermatol Online J. 2021 Apr 15;27(4):13030/qt1qg7x8gf. PMID:33999578.
Hai J, Nguyen M, Kim-Lim P, Wa Cheung K, Jan R, Tartar DM. Characteristics of patients seen at a dermatology free clinic, 2017-2020: a retrospective chart review. Dermatol Online J. 2021 Mar 15;27(3):13030/qt1h32g5pj. PMID:33865291.
Pourang A, Fung MA, Tartar D, Brassard A. Condyloma lata in secondary syphilis. JAAD Case Rep. 2021 Feb 9;10:18-21. doi:10.1016/j.jdcr.2021.01.025. PMID:33732839.
Ladenheim A, Tartar DM, Kiuru M. Polyarthritis, neuropathy, and persistent violaceous plaques. JAAD Case Rep. 2021 Feb 1;15:97-99. doi:10.1016/j.jdcr.2021.01.030. PMID:34466642.
Foolad N, Alber S, Agbai ON, Eisen DB, Tartar D. Characteristics of patients with hidradenitis suppurativa seen at a tertiary care facility from 2009-2019: a retrospective chart review study. Dermatol Online J. 2021 Jan 15;27(1):13030/qt7655j488. PMID:33560801.
Toussi A, Ma C, Tartar DM. Livedo racemosa secondary to hyaluronic acid injection. Dermatol Online J. 2020 Oct 15;26(10):13030/qt78f4g57m. PMID:33147673.
Nguyen M, Hai J, Bovenberg MSS, Wilken R, Kiuru M, Brassard A, Tartar D. A patient with anti-NXP2-positive dermatomyositis and syphilis. Dermatol Online J. 2020 Feb 15;26(2):13030/qt0783v3nx. PMID:32239891..
Nguyen M, Chen YC, Tartar D. Characteristics of patients hospitalized for Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) at a Level 1 trauma center. Dermatol Online J. 2019 Dec 15;25(12):13030/qt98k1f6q4. PMID:32045160.
Tartar DM, Chung L, Fiorentino DF. Clinical significance of autoantibodies in dermatomyositis and systemic sclerosis. Clin Dermatol. 2018 Jul-Aug;36(4):508-524. doi:10.1016/j.clindermatol.2018.04.008. Epub 2018 Apr 12. PMID:30047434.